NO974255L - Preparation for once-daily injection month and useful as a depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women - Google Patents

Preparation for once-daily injection month and useful as a depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women

Info

Publication number
NO974255L
NO974255L NO974255A NO974255A NO974255L NO 974255 L NO974255 L NO 974255L NO 974255 A NO974255 A NO 974255A NO 974255 A NO974255 A NO 974255A NO 974255 L NO974255 L NO 974255L
Authority
NO
Norway
Prior art keywords
once
hormone replacement
replacement therapy
perimenopausal
useful
Prior art date
Application number
NO974255A
Other languages
Norwegian (no)
Other versions
NO974255D0 (en
Inventor
Ursula Lachnit-Fixson
Semiramis Aydinlik
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO974255D0 publication Critical patent/NO974255D0/en
Publication of NO974255L publication Critical patent/NO974255L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det beskrives anvendelse av en enmånedssprøyte ("once-a-month- injectable") som inneholder en østrogen og gestagen komponent som aktive stof- fer for fremstilling av et legemiddel for å hindre befruktning og for sam- tidig hormonerstatningsterapi for kvin- ner omkring og før klimakteriet. Med dette legemiddel oppnås en sikker befruktningshindrende effekt med et "naturlig" østrogen (uten etyn- yløstradiol) med inngående, virksom terapi mot de begynnende østrogenbort- fallsfenomener så vel som en osteo- poroseprevensjon.It is disclosed the use of a once-a-month injectable containing an estrogenic and progestogen component as active substances for the manufacture of a drug to prevent conception and for concurrent hormone replacement therapy for women around and before menopause. With this drug, a safe contraceptive effect is achieved with a "natural" estrogen (without ethynyl estradiol) with incoming, effective therapy for the onset of estrogen loss as well as an osteoporosis prevention.

NO974255A 1995-03-16 1997-09-15 Preparation for once-daily injection month and useful as a depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women NO974255L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19510861A DE19510861A1 (en) 1995-03-16 1995-03-16 One-month injection as a depot contraceptive and for hormone replacement therapy for peri- and premenopausal women
PCT/EP1996/001201 WO1996028165A1 (en) 1995-03-16 1996-03-15 Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women

Publications (2)

Publication Number Publication Date
NO974255D0 NO974255D0 (en) 1997-09-15
NO974255L true NO974255L (en) 1997-11-14

Family

ID=7757668

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974255A NO974255L (en) 1995-03-16 1997-09-15 Preparation for once-daily injection month and useful as a depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women

Country Status (17)

Country Link
EP (1) EP0814811A1 (en)
JP (1) JPH11501649A (en)
KR (1) KR19980703058A (en)
AR (1) AR002283A1 (en)
AU (1) AU713258B2 (en)
CA (1) CA2215382A1 (en)
CZ (1) CZ289697A3 (en)
DE (1) DE19510861A1 (en)
HU (1) HUP9801691A3 (en)
IL (1) IL117516A (en)
MX (1) MX9707009A (en)
NO (1) NO974255L (en)
NZ (1) NZ304027A (en)
PL (1) PL322202A1 (en)
SK (1) SK123997A3 (en)
WO (1) WO1996028165A1 (en)
ZA (1) ZA962177B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Also Published As

Publication number Publication date
AR002283A1 (en) 1998-03-11
IL117516A (en) 2000-07-26
PL322202A1 (en) 1998-01-19
HUP9801691A2 (en) 1998-11-30
IL117516A0 (en) 1996-07-23
JPH11501649A (en) 1999-02-09
MX9707009A (en) 1997-11-29
AU713258B2 (en) 1999-11-25
WO1996028165A1 (en) 1996-09-19
CA2215382A1 (en) 1996-09-19
NO974255D0 (en) 1997-09-15
KR19980703058A (en) 1998-09-05
DE19510861A1 (en) 1996-09-19
EP0814811A1 (en) 1998-01-07
NZ304027A (en) 2000-05-26
ZA962177B (en) 1996-07-29
HUP9801691A3 (en) 1999-03-01
CZ289697A3 (en) 1997-12-17
AU5110896A (en) 1996-10-02
SK123997A3 (en) 1998-02-04

Similar Documents

Publication Publication Date Title
RU2091069C1 (en) Agent for hormonal contraception that inhibits ovulation
RU2169566C2 (en) Method and remedy for creating hormone contraception and/or treating acne
CY1105276T1 (en) TRIPHASIC ORAL CONTRACEPTIVE
KR960704553A (en) PREPARATION FOR SUBSTITUTION THERAPY CONTAINING AT LEAST ONE PROGESTOGEN AND AT LEAST ONE ESTROGEN
NZ234051A (en) Treating post-menopausal disorders using an estrogenic compound mixed with a compound having progestational activity
AU645637B2 (en) Contraceptive regimen
AU645382B2 (en) Low estrogen oral contraceptives
SK178097A3 (en) Pharmaceutical combined preparation, kit and method for hormonal contraception
AU3436097A (en) Progestogen-anti-progestogen regimens
IL94416A (en) Pharmaceutical compositions containing dihydrospirorenone
PL327182A1 (en) Method of preventing conception among female mammals through combined application of gestagen and oestrogen and combination of active agent therefor
WO1994002103A3 (en) Ovulation inhibitor for hormonal contraception
AU707235B2 (en) Competitive progesterone antagonists for demand-oriented female birth control
NO974255L (en) Preparation for once-daily injection month and useful as a depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women
Sample Pharmacology of contraceptive agents-new compounds with new problems?
Wood Hormonal contraception: current perspectives. Part I. An analysis of available agents

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application